
Oncology Nutrition Market Report 2026
Global Outlook – By Cancer Type (Blood Cancer, Breast Cancer, Stomach And Gastrointestinal Cancers, Liver Cancer, Pancreatic Cancer, Other Cancer Types ), By Nutrition (Enteral Nutrition, Parenteral Nutrition), By End-Users (Hospitals, Homecare, Specialty Clinics, Other End Users) - Market Size, Trends, And Global Forecast 2026-2035
Oncology Nutrition Market Overview
• Oncology Nutrition market size has reached to $2.08 billion in 2025 • Expected to grow to $3.27 billion in 2030 at a compound annual growth rate (CAGR) of 9.4% • Growth Driver: Surge In Cancer Prevalence Drives Growth In Oncology Nutrition Market • Market Trend: AEACAP Launches Nutrition Series To Support Cancer Patients And Caregivers • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Oncology Nutrition Market?
Oncology nutrition refers to eating a healthy and balanced diet prescribed for a cancer patient. Eating the right kinds of food before, during, and after treatment can help patients feel better and stay stronger. Oncology nutrition is used to improve clinical outcomes in certain cancer types. The main types of cancer in oncology nutrition are blood cancer, breast cancer, stomach and gastrointestinal cancers, liver cancer, pancreatic cancer, and others. Stomach and gastrointestinal cancers refer to cancers that are caused in any part of the stomach. The different types of nutrition include enteral nutrition and parenteral nutrition and are employed in hospitals, homecare, specialty clinics, and other end users.
What Is The Oncology Nutrition Market Size and Share 2026?
The oncology nutrition market size has grown strongly in recent years. It will grow from $2.08 billion in 2025 to $2.28 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increasing awareness about nutrition in cancer care, growing prevalence of cancer types such as breast, blood, and gastrointestinal cancers, rising hospital and homecare adoption of enteral and parenteral nutrition, development of specialized oncology nutrition formulas, expansion of specialty clinics for cancer care.What Is The Oncology Nutrition Market Growth Forecast?
The oncology nutrition market size is expected to see strong growth in the next few years. It will grow to $3.27 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to rising demand for personalized oncology nutrition plans, increasing adoption of technology-enabled nutrition tracking, growth in homecare and outpatient nutrition services, rising focus on improving patient outcomes through nutrition, expansion of oncology nutrition services in emerging markets. Major trends in the forecast period include rising adoption of digital health platforms for oncology nutrition tracking, increasing integration of ai in personalized cancer diet planning, growing use of genomics and precision medicine in nutritional interventions, rising automation in hospital and homecare nutrition services, increasing iot-enabled monitoring of nutritional supply and patient compliance.Global Oncology Nutrition Market Segmentation
1) By Cancer Type: Blood Cancer, Breast Cancer, Stomach And Gastrointestinal Cancers, Liver Cancer, Pancreatic Cancer, Other Cancer Types 2) By Nutrition: Enteral Nutrition, Parenteral Nutrition 3) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End Users Subsegments: 1) By Blood Cancer: Leukemia, Lymphoma, Multiple Myeloma 2) By Breast Cancer: Early-Stage Breast Cancer, Advanced Breast Cancer 3) By Stomach And Gastrointestinal Cancers: Gastric Cancer, Colorectal Cancer, Esophageal Cancer 4) By Liver Cancer: Hepatocellular Carcinoma, Cholangiocarcinoma 5) By Pancreatic Cancer: Exocrine Pancreatic Cancer, Endocrine Pancreatic Tumors 6) By Other Cancer Types: Lung Cancer, Prostate Cancer, Ovarian Cancer, Head And Neck CancersWhat Is The Driver Of The Oncology Nutrition Market?
An increase in the prevalence of cancer is significantly contributing to the growth of the oncology nutrition market going forward. Cancer incidence refers to the number of new cancer cases arising in a specified population over a given period of time. People suffering from cancer require adequate food with sufficient nutrition. As a result, the rise in the incidence of cancer increases the demand for oncology nutrition. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the rising incidence of cancer will contribute to the growth of the oncology nutrition industry.Key Players In The Global Oncology Nutrition Market
Major companies operating in the oncology nutrition market are B. Braun Melsungen AG, Abbott Laboratories, Abbott Nutrition, Nestle S.A., Nutricia, Baxter International Inc., Fresenius Kabi AG, Fresenius Kabi USA LLC, Global Health Products Inc., Cambrooke Therapeutics Inc., Kate Farms Inc., Real Food Blends LLC, Medtrition Inc., Nutra Balance Products, Nutritional Medicinals LLC, Primus Pharmaceuticals Inc., Solace Nutrition, Unimed Pharma LLC, Vitaflo USA LLC, Danone S.A., Ajinomoto Co Ltd, Otsuka Pharmaceutical Co Ltd, Grifols S.A., Victus Inc, Esperer NutritionGlobal Oncology Nutrition Market Trends and Insights
Major companies operating in the oncology nutrition market are focusing on developing innovative solutions, such as nutrition for cancer patients, to improve treatment outcomes, support immune function, manage treatment-related side effects, and enhance the overall quality of life during and after cancer therapy. Nutrition for cancer patients refers to specialized dietary plans and nutritional interventions designed to meet the unique needs of individuals undergoing cancer treatment. For instance, in June 2024, AEACAP, the Spain-based Patients Support Association, launched a new nutrition series designed to support cancer patients and their caregivers. This initiative features a collection of videos released every two weeks, presented by a specialized nutritionist. The series aims to provide essential information on diet and nutrition during and after cancer treatment, highlighting the critical role that proper nutrition plays in enhancing treatment outcomes and overall quality of life for those affected by cancer.What Are Latest Mergers And Acquisitions In The Oncology Nutrition Market?
In January 2024, Danone S.A., a France-based food company, partnered with National Resilience, Inc. Danone and Resilience have partnered to enhance nutritional care for cancer patients by integrating a specialized nutrition support module into Resilience's digital oncology platform, aiming to address cancer-related malnutrition and improve patient outcomes and quality of life during treatment. National Resilience, Inc., a US-based manufacturing and technology company dedicated to broadening access to complex medicines.Regional Outlook
North America was the largest region in the oncology nutrition market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Oncology Nutrition Market?
The oncology nutrition market includes revenues earned by entities by bladder cancer, breast cancer, colorectal cancer, kidney cancer, and lung cancer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Oncology Nutrition Market Report 2026?
The oncology nutrition market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oncology nutrition industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Oncology Nutrition Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.28 billion |
| Revenue Forecast In 2035 | $3.27 billion |
| Growth Rate | CAGR of 9.6% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Cancer Type, Nutrition, End-Users |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | B. Braun Melsungen AG, Abbott Laboratories, Abbott Nutrition, Nestle S.A., Nutricia, Baxter International Inc., Fresenius Kabi AG, Fresenius Kabi USA LLC, Global Health Products Inc., Cambrooke Therapeutics Inc., Kate Farms Inc., Real Food Blends LLC, Medtrition Inc., Nutra Balance Products, Nutritional Medicinals LLC, Primus Pharmaceuticals Inc., Solace Nutrition, Unimed Pharma LLC, Vitaflo USA LLC, Danone S.A., Ajinomoto Co Ltd, Otsuka Pharmaceutical Co Ltd, Grifols S.A., Victus Inc, Esperer Nutrition |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
